Odyssey Therapeutics, Inc.

Research Odyssey Therapeutics, Inc. (ODTX) on Bullrun: market cap USD 891.12M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerODTX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 891.12M
• Financial periodQ1 2026
• Net income-USD 38.26M
• Free cash flow-USD 41.18M

Valuation Snapshot

latest market cap is USD 891.12M.

About Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic inflammatory responses activation of interferon regulatory factor 5 (IRF5);

Frequently asked questions

What is Odyssey Therapeutics, Inc.'s market cap?

Odyssey Therapeutics, Inc.'s market capitalization is USD 891.12M.

What does Odyssey Therapeutics, Inc. do?

Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases.